Cited by 129Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes.

Buchanan, T A, Xiang, A H, Kjos, S L, Trigo, E, Lee, W P, Peters, R K·1999·Diabetes

Abstract

In this study, we sought to identify antepartum characteristics that predict the de novo development of diabetes 11-26 months after the index pregnancy in a carefully characterized cohort of women with gestational diabetes mellitus (GDM). Oral and frequently sampled intravenous glucose tolerance tests (OGTTs and FSIGTs), hyperinsulinemic-euglycemic clamps with labeled glucose, and body composition studies were performed on 91 islet cell antibody-negative Latino women with GDM during the third trimester of pregnancy. The women were documented to be diabetes-free within 6 months postpartum. Their diabetes status was ascertained again between 11 and 26 months postpartum. Logistic regression analysis was used to identify independent predictors of the development of diabetes within that interval. Fourteen of the women developed diabetes by World Health Organization criteria 11-26 months after delivery of the index pregnancy. Three antepartum variables were independent predictors of diabetes: the 1-h postchallenge plasma glucose concentration from the 100-g OGTT at which GDM was diagnosed (higher = increased risk; P = 0.003); an index of pancreatic beta-cell compensation for insulin resistance, defined as the product of the 30-min incremental plasma insulin:glucose ratio on a 75-g OGTT and the insulin sensitivity index from a hyperinsulinemic-euglycemic clamp (lower = increased risk, P = 0.009); and the basal glucose production rate after an overnight fast (higher = increased risk; P = 0.04). We conclude that postchallenge hyperglycemia, poor pancreatic beta-cell compensation for insulin resistance, and elevated endogenous glucose production during pregnancy precede the development of type 2 diabetes in young Latino women by at least 1-2 years.

Integrity signals

Registry

Crossref · 10.2337/diabetes.48.12.2430

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Subjects at high risk of developing Type 2 diabetes, including first-degree relatives, women with a history of gestational diabetes or polycystic ovarian disease, older subjects, and subjects with impaired glucose tolerance, have diminished beta-cell function, manifest as a reduced first-phase insulin response to intravenous glucose relative to insulin sensitivity, even when many still have NGT.

    “Based on the concept of a feedback loop, it has become evident that subjects who are at high risk of developing Type 2 diabetes have diminished beta-cell function at a time when many of them still have NGT.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Buchanan, T. A., Xiang, A. H., Kjos, S. L., Trigo, E., Lee, W. P., & Peters, R. K.
Affiliations
University of Southern California (US)
Venue
Diabetes
Published
1999-12-01
Volume
48
Issue
12
Pages
2430-2436
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W1966633426
Cited by
129
References
17
Citations by year
2026: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 2 · 2019: 2 · 2018: 7 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 11 · 2013: 5 · 2012: 6
FWCI
4.85
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK 17047, R01DK046374, R01DK46374, P30DK017047)
  • National Center for Research Resources (M01 RR-43)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
gestational diabetes mellitus, type 2 diabetes, Hispanic women, postpartum diabetes risk, beta-cell compensation, insulin resistance, endogenous glucose production, hyperinsulinemic-euglycemic clamp, oral glucose tolerance test, islet cell antibodies
MeSH terms
Adult, Blood Glucose, Body Composition, California, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Hispanic or Latino, Humans, Insulin, Longitudinal Studies, Predictive Value of Tests, Pregnancy, Prognosis, Time Factors, Glucose Clamp Technique, Cohort Studies, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review